Hält derzeit Positionen bei Allergan Inc, Allergan Finance LLC and Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Executive Vice President | Allergan Inc | None - |
Executive Vice President Commercial, North American Brands | Allergan Finance LLC | 1. Juli 2014 - |
Independent Director | Syndax Pharmaceuticals Inc | 25. September 2018 - |
Executive Vice President, Chief Commercial Officer | Allergan plc | 1. Mai 2016 - 8. Mai 2020 |
Executive Vice President Commercial, North American Brands | Allergan plc | 1. Juli 2014 - 1. März 2015 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-03 | 2023-08-02 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
24.000
-33.3%
20,45490.913 USD |
24.000 -33.3% | 20,45 | 490.913 USD | |
2023-08-03 | 2023-08-02 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
24.000
-33.3%
20,46490.951 USD |
24.000 -33.3% | 20,46 | 490.951 USD | |
2023-08-03 | 2023-08-02 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Verkauf |
35.000
-42.2%
20,46715.946 USD |
35.000 -42.2% | 20,46 | 715.946 USD |